Our objective was to examine the interaction between Tregs and GSCs in patients with glioma, dissecting the underlying molecular mechanisms whereby Tregs promote GSCs via the TGF-β–NF-κB–IL6–STAT3 axis. This evidence concerns the gene STAT3 and glioma.